Euro
USD
British Pound
NULL
Product Description
L-JNK Peptide Inhibitor competitively blocks the interaction between JNK and c-Jun, thereby inhibiting the signaling events downstream of JNK, like c-Jun, ATF-2 and ELK1 phosphorylation. To convert JIP-1/IB-1 into cell permeable inhibitors of JNK (JNKI1) the minimal 20 amino acids inhibitory sequence of JIP-1/IB1 was covalently linked to the 10 amino acids recognized by TAT transporter. The L-JNKI1 is a potent inhibitor that is specific for JNK and can be used for in vitro applications.
L-JNK Peptide Inhibitor competitively blocks the interaction between JNK and c-Jun, thereby inhibiting the signaling events downstream of JNK, like c-Jun, ATF-2 and ELK1 phosphorylation. To convert JIP-1/IB-1 into cell permeable inhibitors of JNK (JNKI1) the minimal 20 amino acids inhibitory sequence of JIP-1/IB1 was covalently linked to the 10 amino acids recognized by TAT transporter. The L-JNKI1 is a potent inhibitor that is specific for JNK and can be used for in vitro applications.
Biovision | 7011 | L-JNK Peptide Inhibitor I DataSheet
Alternate Name/Synonyms:
Appearance: Liquid
Formulation: 1 mM (PBS)
CAS Number: N/A
Structure Available?: No
Peptide sequence: GRKKRRQRRR-PP-RPKRPTTLNLFPQVPRSQD-amide
Salt Form: No
Molecular Formula: C₁₆₄H₂₈₆N₆₆O₄₀
Molecular Weight: 3822.5
Cell-Permeable?: Yes
Purity: ≥97% by HPLC
Solubilities: N/A
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A cell-permeable JNK inhibitor
MDL Number: MFCD12912420
PubChem CID: N/A
SMILES: N/A
InChi: N/A
InChi Key: N/A
